Blood contacting medical devices are those devices that come in contact with blood during diagnosis, treatment, or surgery.
Blood contacting medical devices are those devices that come in contact with blood during diagnosis, treatment, or surgery. Medical devices such as cardiovascular devices, dialysis devices, catheters, and implantable devices come in contact with blood. Most blood contacting devices are implantable, and they help in the normal functioning of vital organs. The specific surface modification requirement of a blood contacting device depends on the time span that the device will be in contact with blood. Blood contacting medical devices are made of synthetic materials. When blood comes in contact with these materials that are foreign to the body, a number of adverse reactions are initiated. These reactions include platelet activation, platelet attachment, and complement activation. They eventually lead to clot formation and fibrin production. Thrombus development is a common cause of failure of blood contacting medical devices. This is because artificial biomaterials endorse clotting through a complex series of connected processes that include adhesion of platelets, protein adsorption, leukocytes and thrombin generation, and red blood cells and complement activation.
Read Report Overview: https://www.transparencymarketresearch.com/blood-contacting-medical-devices-market.html
Factors such as the risk of contamination of blood contacting device during or after the treatment and cost of these devices is likely to hamper the global market for blood contacting devices.
The global blood contacting medical devices market can be segmented based on product, application, end-user, and region. Based on product, the global blood contacting medical devices market can be categorized into short-term blood contacting devices, long-term blood contacting devices, and implantable blood contacting devices. Short-term blood contacting devices are introducers or catheters that also need a lubricious surface. Antiadherent blood-compatible coverings are often hydrogels that are lubricious when wet. Therefore, they can concurrently provide the dual surface developments of hemocompatibility and lubricity. Long-term blood contacting devices, such as cardiovascular devices, are used to assist various heart failure conditions. The most common blood contacting cardiovascular device is the stent. Stents are used for opening an artery that is blocked by growth of plaque. They help keep the coronary arteries open, thus reducing the risk of heart attacks. There are different types of stents such as bare metal stents, drug eluting stents, and bioresorbable stents. The implantable blood contacting devices segment can be further categorized into orthopedic implantable devices, cardiovascular implantable devices, and other medical implantable devices. In terms of applications, the global blood contacting medical devices market can be categorized into spine surgery, gynecological surgery, orthopedic surgery, neurological surgery, urological surgery, and other surgeries. Based on end-user, the global blood contacting medical devices market can be categorized into hospitals, specialty clinics, ambulatory surgery centers, and others.
Request Brochure of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=61248
In terms of geography, the blood contacting medical devices market can be categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global blood contacting medical devices market, due to the availability of better treatment options and rapid change in lifestyle. Moreover, a rise in the number of individuals undergoing treatment for life threatening diseases and better reimbursement facilities are expected to augment the market in the region. Europe is a prominent region of the blood contacting medical devices market. The blood contacting medical devices market in Asia Pacific is expected to be driven by the presence of local players in the market in the region, increase in prevalence of life threatening diseases such as cardiovascular disorders, and increase in organ failure.
Request for Covid-19 Impact Analysis: https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=61248
Some of the key players operating in blood contacting medical devices market are SynCardia Systems, LLC, Berlin Heart, HeartWare, Lifetech Scientific, Abbott, Boston Scientific Corporation, and Medtronic.
More Trending Reports by Transparency Market Research:
Blood Coagulation Factor Market: The capability of our body cells to cease blood loss following a vascular injury by forming blood clot is vital to sustain health. Coagulation or clotting is the process of converting the liquid blood into a gel like clot to cease bleeding.
Blood Culture Tests Market: Blood culture tests are done to detect the presence of microorganisms such as bacteria or fungi in the blood. It is used to determine the presence of infection, identify the causative agents and to guide the proper treatment required to a patient.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453